SpaceX (NASDAQ:SPCX) has given back its post-IPO gains, but the round trip toward the offering price is exactly why I'm sharpening my pencil.
Evercore ISI has launched coverage on SpaceX (NASDAQ:SPCX) with an Outperform rating and a $230 price target, adding a high-profile bull voice just as the newly public shares cool off.
Global conflicts have a way of reshaping investment stories overnight.
When it comes to space stocks, Elon Musk's SpaceX (SPCX) is clearly the big kahuna. After all, the company just completed the largest initial public offering (IPO) in history, rapidly joining the $1 trillion-plus market capitalization club in the process.
Joel Shulman says SpaceX (SPCX) is his firm's top holding and believes the current post-sell-off price is a good buying opportunity. He makes the case that the Elon Musk-led company is a "20-year hold.
SpaceX stock is dangerously close to falling below its IPO price.
SpaceX (NASDAQ: SPCX) has erased approximately $1.2 trillion in market value within a month of its historic public debut, as a sharp selloff reversed much of the stock's post-IPO rally.
SpaceX (SPCX) has been trading publicly for a month now, and shares have since fallen below the company's IPO price. Luke Lloyd expects downside pressure to continue toward $100.
Shares of SpaceX are boldly going where they haven't gone before.
SPCX has fallen 35% from its peak, but Starlink profits, Starship progress and AI ambitions support a hold-and-watch approach.
SpaceX stock (SPCX) fell for a second consecutive trading session on Monday, moving closer to the company's $135 initial public offering price just days after joining the Nasdaq-100 index. The stock declined more than 4% to trade around $139 as broader US equity markets also came under pressure.
SpaceX has gotten on my speculative buy list, driven by its highly ambitious AI transformation and potential for explosive long-term growth. Current AI revenue is nascent, but projections suggest AI could comprise over 90% of SPCX's business by 2030, with revenue estimates reaching $365B. Execution risk is extremely high, with wide-ranging price targets ($62–$800) and significant near-term volatility expected due to insider share unlocks through 2027.